Pregabalin Patent Expiration
Pregabalin is Used for treating neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia. It was first introduced by Upjohn Us 2 Llc
Pregabalin Patents
Given below is the list of patents protecting Pregabalin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Lyrica Cr |
US10022447 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
Lyrica Cr |
US8945620 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
Lyrica Cr |
US9144559 (Pediatric) | Solid pharmaceutical compositions containing pregabalin | May 02, 2027 | Upjohn |
Lyrica Cr | US10022447 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
Lyrica Cr | US8945620 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
Lyrica Cr | US9144559 | Solid pharmaceutical compositions containing pregabalin | Nov 02, 2026 | Upjohn |
Lyrica |
US6001876 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
Lyrica |
US6197819 (Pediatric) | Gamma amino butyric acid analogs and optical isomers |
Jun 30, 2019
(Expired) | Upjohn |
Lyrica |
USRE41920 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
Lyrica Cr |
US6197819 (Pediatric) | Gamma amino butyric acid analogs and optical isomers |
Jun 30, 2019
(Expired) | Upjohn |
Lyrica Cr |
USRE41920 (Pediatric) | Isobutylgaba and its derivatives for the treatment of pain |
Jun 30, 2019
(Expired) | Upjohn |
Lyrica | US6001876 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
Lyrica | US6197819 | Gamma amino butyric acid analogs and optical isomers |
Dec 30, 2018
(Expired) | Upjohn |
Lyrica | USRE41920 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
Lyrica Cr | US6197819 | Gamma amino butyric acid analogs and optical isomers |
Dec 30, 2018
(Expired) | Upjohn |
Lyrica Cr | USRE41920 | Isobutylgaba and its derivatives for the treatment of pain |
Dec 30, 2018
(Expired) | Upjohn |
Lyrica | US5563175 | GABA and L-glutamic acid analogs for antiseizure treatment |
Oct 08, 2013
(Expired) | Upjohn |
Pregabalin's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List